PAYER POLICY CHANGES

S2120 Insurance Policy Changes

HCPCS S2120 is officially defined as "Low density lipoprotein (ldl) apheresis using heparin-induced extracorporeal ldl precipitation." HCPCS S2120 is referenced in 4 tracked payer policy changes from Blue Cross Blue Shield of North Dakota, Blue Cross & Blue Shield of Mississippi, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS S2120 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch S2120

Get one email when a payer policy names S2120, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for S2120

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for S2120 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.